A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study
<p>Abstract</p> <p>Background</p> <p>Adequate anticoagulation is prerequisite for effective hemodialysis to prevent clotting in the extracorporeal circuit. We aimed providing first data on the efficacy and safety of the low-molecular-weight heparin certoparin in this setting.</p> <p>Methods</p> <p>M...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2012-06-01
|
| Серія: | BMC Nephrology |
| Онлайн доступ: | http://www.biomedcentral.com/1471-2369/13/50 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|